The Supreme Court is considering a lawsuit meant to reverse the Food and Drug Administration’s approval of the abortion pill mifepristone. The case has major ramifications for abortion access, given that a majority of abortions are now performed via medication. It also could reshape the 2024 elections, in which abortion is expected to be a significant consideration for voters. The Washington Examiner is featuring a series of articles providing an in-depth look at the case and its implications. Previous entries included the basic facts of the case and the science of the abortion pill. This entry is a report on the political ramifications of the Supreme Court’s decision.

The Supreme Court’s impending judgment on the Food and Drug Administration’s changes to the approval of the abortion pill mifepristone is expected to loom large over the 2024 election between President Joe Biden and former President Donald Trump.